Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling for Treating Alopecia Areata

April 2023 in “ Polymers ”

Mohammed Muqtader Ahmed, Farhat Fatima, Aisha Alnami, Mohammad A. Alsenaidy, Alhussain Aodah, Mohammed F. Aldawsari, Bjad K. Almutairy, Md. Khalid Anwer, Mohammed Jafar

baricitinib alopecia areata fused deposition modeling polylactic acid PLA 3D-printed pills Korsmeyer-Peppas model JAK inhibitor BAB 3DP1 3DP2

TLDR The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

This study developed and characterized 3D-printed pills incorporating Baricitinib (BAB) using polylactic acid (PLA) filaments through fused deposition modeling (FDM) to treat alopecia areata (AA). The pills, designed with a central hole to enhance drug release, were tested for drug encapsulation, release properties, and stability. Results showed drug release rates of 43.76% and 59.14% over 24 hours for 2% and 4% BAB concentrations, respectively, following the Korsmeyer–Peppas model. The study concluded that these 3D-printed pills could effectively deliver BAB with improved bioavailability and sustained release, offering a low-cost, personalized treatment option for AA.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Two Phase 3 Trials of Baricitinib for Alopecia Areata

148 citations, March 2022 in “The New England Journal of Medicine”

Baricitinib was effective in treating alopecia areata in two major trials.

research Alopecia Areata: An Autoimmune Disease of Multiple Players

31 citations, July 2021 in “ImmunoTargets and therapy”

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

research A Comprehensive Literature Review of JAK Inhibitors in the Treatment of Alopecia Areata

40 citations, June 2021 in “Clinical, cosmetic and investigational dermatology”

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

research The Role of Family History and Its Influence on the Onset Time in Female Pattern Hair Loss

1 citations, January 2020 in “Postepy Dermatologii I Alergologii”

Family history, especially on the mother's side, increases the risk of female pattern hair loss.

research Immunology of Alopecia Areata

23 citations, January 2020 in “Central-European Journal of Immunology/Central European Journal of Immunology”

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

research Minoxidil And Its Use In Hair Disorders: A Review

117 citations, August 2019 in “Drug Design Development and Therapy”

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

research JAK Inhibitors for Treatment of Alopecia Areata

63 citations, July 2018 in “The journal of investigative dermatology/Journal of investigative dermatology”

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

research Alopecia Areata: Part 2: Treatment

14 citations, September 2015 in “PubMed”

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

research Epidemiology and Burden of Alopecia Areata: A Systematic Review

144 citations, July 2015 in “Clinical, Cosmetic and Investigational Dermatology”

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

research Alopecia Areata: A New Treatment Plan

67 citations, July 2011 in “Clinical, cosmetic and investigational dermatology”

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Similar Research

5 / 397 results

research Folliculitis Decalvans: A Review of Current Treatment Modalities

May 2024 in “Journal of Education, Health and Sport”

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

research Gut Microbiota and Its Association with Alopecia Areata: Insights from a Two-Sample Mendelian Randomization Study

July 2023 in “Research Square (Research Square)”

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

research Androgenetic Alopecia: Therapy Update

May 2023 in “Drugs”

There are many treatments for common hair loss, but more trials are needed to decide which are best.

research Integrated Safety Analysis of Baricitinib in Adults With Severe Alopecia Areata From Two Randomized Clinical Trials

25 citations, November 2022 in “British journal of dermatology/British journal of dermatology, Supplement”

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

research Baseline Distribution of Eyebrow and Eyelash Loss by Severity of Scalp Hair Loss in Phase 3 Trials of Baricitinib for Alopecia Areata

September 2023 in “Journal of The American Academy of Dermatology”

The document's conclusion cannot be provided because the content is not available.